Cost‐Effectiveness Ratio Analysis of LBBaP Versus BVP in Heart Failure Patients With LBBB
LBBaP-CRT is more cost-effective than BVP, offering greater LVEF improvement, higher echocardiographic response rates, lower hospitalization costs, and more significantly improved cardiac function. These findings need large randomized clinical trials for further confirmation.
Authors
- Jiangang Zou (ORCID: https://orcid.org/0000-0001-5891-6589)
- Zhixin Jiang (ORCID: https://orcid.org/0000-0003-0139-2352)
- Siyuan Xue (ORCID: https://orcid.org/0009-0000-2013-3706)
- Fengwei Zou (ORCID: https://orcid.org/0000-0001-6355-8843)
- Shengchan Wang
- Shigeng Zhang (ORCID: https://orcid.org/0000-0003-2033-4772)
- Xiujuan Zhou (ORCID: https://orcid.org/0000-0001-8452-5354)
- Qijun Shan
- Xiaofeng Hou
- Wen Yang (ORCID: https://orcid.org/0000-0002-2032-1982)
Institutions
- Albert Einstein College of Medicine (US)
- Montefiore Medical Center (US)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Pacing and Clinical Electrophysiology
- Published
- 2024-09-28
- DOI
- https://doi.org/10.1111/pace.15077
- Citations
- 8
- Primary Topic
- Cardiac pacing and defibrillation studies
- Type
- article
- Field-Weighted Citation Impact
- 3.22
Funders
- National Natural Science Foundation of China